JPS6253494B2 - - Google Patents
Info
- Publication number
- JPS6253494B2 JPS6253494B2 JP5721080A JP5721080A JPS6253494B2 JP S6253494 B2 JPS6253494 B2 JP S6253494B2 JP 5721080 A JP5721080 A JP 5721080A JP 5721080 A JP5721080 A JP 5721080A JP S6253494 B2 JPS6253494 B2 JP S6253494B2
- Authority
- JP
- Japan
- Prior art keywords
- absorption spectrum
- ester
- salts
- carboxylic acid
- infrared absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NXIASLUNMKAUTN-WFKFIOEPSA-N ML-236C Chemical class C([C@@H]1[C@H]2CCCC=C2C=C[C@@H]1C)C[C@@H]1C[C@@H](O)CC(=O)O1 NXIASLUNMKAUTN-WFKFIOEPSA-N 0.000 claims description 22
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- -1 ML-236C carboxylic acid esters Chemical class 0.000 description 22
- 238000000862 absorption spectrum Methods 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 235000011116 calcium hydroxide Nutrition 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 1
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はML−236Cカルボン酸エステルおよび
カルボン酸金属塩に関するものである。
ML−236C自体は既知化合物であり(特開昭51
−136886)、次の構造式を有する。
そしてこの化合物がカルボン酸エステルまたは
カルボン酸金属塩を形成するときは、この中のラ
クトン環が開環し、式()の構造式をもつ化合
物が形成される。本発明は式()で示される
ML−236Cカルボン酸エステルまたはカルボン酸
金属塩(以下、ML−236C誘導体という。)を対
象とするものである。
上記式中、Rはメチル、エチル、n−プロピ
ル、イソプロピル、n−ブチル、n−ヘキシルな
どのアルキル基;ベンジル基;或いは1/n・Mを
示し、Mは金属元素、nは該金属元素の原子価を
示す。
ML−236Cの金属塩としてはナトリウム、カリ
ウムなどのアルカリ金属塩、カルシウム、マグネ
シウムなどのアルカリ土類金属塩、およびアルミ
ニウム塩、鉄塩、亜鉛塩、銅塩、ニツケル塩およ
びコバルト塩などがあげられるが、この中、アル
カリ金属塩、アルカリ土類金属塩およびアルミニ
ウム塩が好適であり、さらにナトリウム塩、カル
シウム塩およびアルミニウム塩が最も好適であ
る。
前記式()で示されるML−236C誘導体は新
規化合物であり、この中ML−236Cカルボン酸金
属塩は、ML−236Cを弱アルカリによりケン化す
ることによつて得られる。またML−236Cカルボ
ン酸エステルは例えば次の方法によつて製造する
ことができる。
ML−236Cをアルコールと反応させる。この
際、触媒として塩酸、硫酸などの無機酸あるい
はフツ化ホウ素、酸性イオン交換樹脂などが用
いられ、溶剤としては同一のアルコール、また
はベンゼン、クロロホルム、エーテル等反応に
関与しないものが用いられる。
ML−236Cカルボン酸の金属塩にハロゲン化
アルキルを反応させる。このとき、溶剤として
はジメチルホルムアミド、テトラヒドロフラ
ン、ジメチルスルホキシド、アセトンなどが用
いられる。
ML−236Cカルボン酸をの場合と同様にし
てアルコールと反応させる。(ML−236Cカル
ボン酸は、ML−236Cカルボン酸の金属塩を中
和することによつて得られる。)
以下、実施例により、一般式()で示される
ML−236C誘導体の製造法をさらに詳細に説明す
る。
実施例 1
ML−236Cメチルエステル
ML−236C(2.9g、0.01mol)を乾燥メタノー
ル(70ml)に溶解し、アンバーライトIR−120
(8.0g)を加え3時間煮沸還流する。反応終了
後、樹脂を別し、溶媒を留去して油状物を得
る。この油状物をシリカゲル(100g)のフラシ
ユクロマトグラフイーに付しベンゼン−酢酸エチ
ル(3:1)の溶媒系で展開し分離、精製し、
ML−236Cメチルエステル(1.6g)を得る。こ
のものをn−ヘキサン−エーテルから結晶化さ
せ、白色針状結晶のML−236Cメチルエステル
(0.8g)を得た。
元素分析値
実測値 C;70.91、H;9.47
理論値 C;70.77、H;9.38
質量分析値M+322(C19H30O4)
融点58〜59℃
紫外線吸収スペクトラム:
λエタノールnaX231、238、246mμ
赤外線吸収スペクトラム:第1図に示す
核磁気共鳴スペクトラム:(60MHz、CDCl3)
5.93(二重線H)、5.76(二重、二重線H)、
5.48(多重線H)、4.23(多重線H)、3.88(多
重線H)、3.68(一重線3H)、3.37(多重線
H)、2.45(二重線2H)、2.2〜1.0(17H)、0.87
(二重線3H)
実施例 2
ML−236Cエチルエステル
ML−236C(2.9g、0.01mol)を用いて実施例
1と同様な処理を乾燥エタノールを使用して行
い、得られたML−236Cエチルエステル(1.3
g)をn−ヘキサン−エーテルから結晶化させ、
白色針状晶のML−236Cエチルエステル(0.6
g)を得た。
元素分析値
実測値 C;70.27、H;9.60
理論値 C;71.39、H;9.59
質量分析値M+336(C20H32O4)
融点66.5〜67.5℃
紫外線吸収スペクトラム:
λエタノールnaX231、238、246mμ
赤外線吸収スペクトラム:第2図に示す
核磁気共鳴スペクトラム:(60MHz、CDCl3)
5.83(二重線H)、5.64(二重、二重線H)、
5.37(多重線H)、4.05(四重線2H)、3.68(多
重線H)、3.21(多重線H)、2.37(二重線
2H)、2.2〜1.0(17H)、1.21(三重線3H)、
0.86(二重線3H)
実施例 3
ML−236Cn−ブチルエステル
ML−236C(2.9g、0.01mol)を用いて実施例
1と同様な処理を乾燥n−ブタノールを使用して
行い、得られたML−236Cn−ブチルエステル
(0.8gr)をn−ヘキサン−エーテルから結晶化さ
せ白色針状晶のML−236Cn−ブチルエステル
(0.4g)を得た。
元素分析値
実測値 C;72.32、H;9.84
理論値 C;72.49、H;9.96
質量分析値M+336(C22H36O4)
融点65.5〜66℃
紫外線吸収スペクトラム:
λエタノールnaX231、238、246mμ
赤外線吸収スペクトラム:第3図に示す
実施例 4
ML−236Cベンジルエステル
ML−236Cナトリウム塩(1.65、0.005mol)を
乾燥ジメチルホルムアミド(10ml)に溶解し、こ
れに臭化ベンジル(0.94gr、約0.67ml)を加え室
温で2時間30分間撹拌する。反応液を減圧濃縮
し、濃縮物を酢酸エチルに溶解し、この酢酸エチ
ル層を水洗、乾燥後、溶媒を留去する。得られた
油状物をシリカゲル・フラシユクロマトグラフイ
ー(ベンゼン:酢酸エチル1:1v/v%)で精
製すると油状物(0.8g、収率40%)を得る。こ
の油状物をn−ヘキサン−エーテルで結晶化して
白色針状晶のML−236Cベンジルエステル(0.3
g)を得た。
元素分析値
実測値 C;74.84、H;8.52
理論値 C;75.34、H;8.60
質量分析値M+398(C25H34O4)
融点68〜69℃
赤外線吸収スペクトラム:第4図に示す
核磁気共鳴スペクトラム:(60MHz、CDCl3)
7.40(一重線5H)、5.96(二重線H)、5.77(二
重線、二重線H)、5.53(多重線H)、5.17(一
重線2H)、4.31(幅広い多重線H)、3.77(幅広
い一重線)、2.51(二重線2H)、2.5〜1.0
(17H)、0.85(二重線3H)
実施例 5
ML−236Cナトリウム塩
ML−236C(6.0g、0.02mol)を0.1NNaOH
(200ml)に懸濁させ、80〜90℃で1時間加熱す
る。冷却後、反応液を別、エーテル洗浄して未
反応のML−236Cを除き、水層を凍結乾燥する。
白色吸湿性粉末のML−236Cナトリウム塩(7.3
g)を得た。
赤外線吸収スペクトラム:第5図に示す
実施例 6
ML−236Cカルシウム塩
200mlビーカー中、ML−236C(1.5g、
0.005mol)をメタノール(15ml)とメチレンクロ
ライド(25ml)の混合溶媒に溶解し、これに水
(15ml)と消石灰(5.6g、0.0075mol)を加え
る。反応液を室温で30分間超音波洗浄器にかけ
る。薄層クロマトグラフイーで原料のML−236C
の消失を確認した時点で反応液を過し余分の消
石灰を除去する。水層をメチレンクロライドで抽
出し、このメチレンクロライド液を過したのち
水洗し無水硫酸ナトリウム上で乾燥し溶媒を留去
すると無水油状物を得る。この油状物にn−ヘキ
サンを加えて超音波処理で粉末化したのち過
し、沈澱物を乾燥すると白色粉末(1.3gr、収率
81%)を得る。
元素分析値
実測値 C;64.63、H;8.39
理論値 C;66.02、H;8.31
融点>200℃(分解点)
赤外線吸収スペクトラム:第6図に示す
式()で示されるML−236C誘導体はML−
236Cと同様に肝のコレステロール合成を阻害す
る。しかしながらその作用はML−236Cよりも強
力である。したがつて式()で示されるML−
236C誘導体は高脂血症治療剤、動脈硬化予防薬
として医薬に使用することができる。
次にML−236C誘導体のコレステロール合成阻
害作用を示す。
コレステロール合成阻害作用
ML−236C誘導体はコレステロール合成経路上
の律速酵素として知られる3−ヒドロキシ−3−
メチルグルタリル・コエンザイムAリダクターゼ
(3−hydroxy−3−methylglutaryl−Co
Areductase)を特異的に阻害することが分つ
た。これら化合物のコレステロール合成阻害作用
〔ジヤーナル・オブ・バイオロジカル・ケミスト
リー(J.Biol.Chem.)234巻2835頁(1959年)記
載の方法で測定〕を第1表に示す。
【表】DETAILED DESCRIPTION OF THE INVENTION The present invention relates to ML-236C carboxylic acid esters and carboxylic acid metal salts. ML-236C itself is a known compound.
-136886), has the following structural formula. When this compound forms a carboxylic acid ester or carboxylic acid metal salt, the lactone ring therein opens to form a compound having the structural formula of formula (). The present invention is represented by the formula ()
The target is ML-236C carboxylic acid ester or carboxylic acid metal salt (hereinafter referred to as ML-236C derivative). In the above formula, R represents an alkyl group such as methyl, ethyl, n-propyl, isopropyl, n-butyl, n-hexyl; a benzyl group; or 1/n·M, M is a metal element, and n is the metal element. Indicates the valence of Metal salts of ML-236C include alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, aluminum salts, iron salts, zinc salts, copper salts, nickel salts, and cobalt salts. However, among these, alkali metal salts, alkaline earth metal salts and aluminum salts are preferred, and sodium salts, calcium salts and aluminum salts are most preferred. The ML-236C derivative represented by the above formula () is a new compound, and among these, the ML-236C carboxylic acid metal salt can be obtained by saponifying ML-236C with a weak alkali. Further, ML-236C carboxylic acid ester can be produced, for example, by the following method. React ML-236C with alcohol. In this case, as a catalyst, an inorganic acid such as hydrochloric acid or sulfuric acid, or boron fluoride, or an acidic ion exchange resin is used, and as a solvent, the same alcohol or one that does not participate in the reaction, such as benzene, chloroform, or ether, is used. ML-236C carboxylic acid metal salt is reacted with alkyl halide. At this time, dimethylformamide, tetrahydrofuran, dimethyl sulfoxide, acetone, etc. are used as the solvent. ML-236C carboxylic acid is reacted with alcohol in the same manner as in . (ML-236C carboxylic acid can be obtained by neutralizing a metal salt of ML-236C carboxylic acid.) Hereinafter, based on an example, the general formula () is represented by
The method for producing the ML-236C derivative will be explained in more detail. Example 1 ML-236C methyl ester ML-236C (2.9 g, 0.01 mol) was dissolved in dry methanol (70 ml) and Amberlite IR-120
(8.0g) and boil under reflux for 3 hours. After the reaction is completed, the resin is separated and the solvent is distilled off to obtain an oil. This oil was subjected to flash chromatography on silica gel (100 g), developed with a solvent system of benzene-ethyl acetate (3:1), separated and purified,
ML-236C methyl ester (1.6 g) is obtained. This product was crystallized from n-hexane-ether to obtain ML-236C methyl ester (0.8 g) as white needle-like crystals. Elemental analysis values Actual value C; 70.91, H; 9.47 Theoretical value C; 70.77, H; 9.38 Mass analysis value M + 322 (C 19 H 30 O 4 ) Melting point 58-59°C Ultraviolet absorption spectrum: λethanol naX 231, 238 , 246mμ Infrared absorption spectrum: Nuclear magnetic resonance spectrum shown in Figure 1: (60MHz, CDCl 3 )
5.93 (double line H), 5.76 (double, double line H),
5.48 (multiplet H), 4.23 (multiplet H), 3.88 (multiplet H), 3.68 (singlet 3H), 3.37 (multiplet H), 2.45 (doublet 2H), 2.2~1.0 (17H), 0.87
(Double line 3H) Example 2 ML-236C ethyl ester ML-236C (2.9 g, 0.01 mol) was treated in the same manner as in Example 1 using dry ethanol, and the obtained ML-236C ethyl ester Ester (1.3
g) is crystallized from n-hexane-ether;
ML-236C ethyl ester (0.6
g) was obtained. Elemental analysis values Actual value C; 70.27, H; 9.60 Theoretical value C; 71.39, H; 9.59 Mass analysis value M + 336 (C 20 H 32 O 4 ) Melting point 66.5-67.5°C Ultraviolet absorption spectrum: λethanol naX 231, 238 , 246mμ Infrared absorption spectrum: Nuclear magnetic resonance spectrum shown in Figure 2: (60MHz, CDCl 3 )
5.83 (double line H), 5.64 (double, double line H),
5.37 (Multiplet H), 4.05 (Quadruplet 2H), 3.68 (Multiplet H), 3.21 (Multiplet H), 2.37 (Doublet
2H), 2.2~1.0 (17H), 1.21 (triple line 3H),
0.86 (double line 3H) Example 3 ML-236Cn-butyl ester ML-236C (2.9 g, 0.01 mol) was treated in the same manner as in Example 1 using dry n-butanol. ML-236Cn-butyl ester (0.8gr) was crystallized from n-hexane-ether to give ML-236Cn-butyl ester (0.4g) as white needles. Elemental analysis values Actual value C; 72.32, H; 9.84 Theoretical value C; 72.49, H; 9.96 Mass analysis value M + 336 (C 22 H 36 O 4 ) Melting point 65.5-66°C Ultraviolet absorption spectrum: λethanol naX 231, 238 , 246 mμ. 0.67 ml) and stirred at room temperature for 2 hours and 30 minutes. The reaction solution is concentrated under reduced pressure, the concentrate is dissolved in ethyl acetate, the ethyl acetate layer is washed with water, dried, and the solvent is distilled off. The obtained oil was purified by silica gel flash chromatography (benzene:ethyl acetate 1:1 v/v%) to obtain an oil (0.8 g, yield 40%). This oil was crystallized from n-hexane-ether to form white needles of ML-236C benzyl ester (0.3
g) was obtained. Elemental analysis values Actual value C; 74.84, H; 8.52 Theoretical value C; 75.34, H; 8.60 Mass analysis value M + 398 (C 25 H 34 O 4 ) Melting point 68-69°C Infrared absorption spectrum: Nuclei shown in Figure 4 Magnetic resonance spectrum: (60MHz, CDCl3 )
7.40 (Singlet 5H), 5.96 (Double H), 5.77 (Double, Doublet H), 5.53 (Multiplet H), 5.17 (Singlet 2H), 4.31 (Broad Multiplet H), 3.77 (wide singlet), 2.51 (double 2H), 2.5~1.0
(17H), 0.85 (double line 3H) Example 5 ML-236C sodium salt ML-236C (6.0g, 0.02mol) in 0.1NNaOH
(200 ml) and heated at 80-90°C for 1 hour. After cooling, the reaction solution is separated, washed with ether to remove unreacted ML-236C, and the aqueous layer is freeze-dried.
White hygroscopic powder ML-236C sodium salt (7.3
g) was obtained. Infrared absorption spectrum: Example shown in Figure 5 6 ML-236C calcium salt In a 200 ml beaker, ML-236C (1.5 g,
Dissolve 0.005 mol) in a mixed solvent of methanol (15 ml) and methylene chloride (25 ml), and add water (15 ml) and slaked lime (5.6 g, 0.0075 mol) to this. Place the reaction solution in an ultrasonic cleaner for 30 minutes at room temperature. Raw material ML-236C using thin layer chromatography
When the disappearance of the lime is confirmed, the reaction solution is filtered to remove excess slaked lime. The aqueous layer is extracted with methylene chloride, and the methylene chloride solution is filtered, washed with water, dried over anhydrous sodium sulfate, and the solvent is distilled off to obtain an anhydrous oil. N-hexane was added to this oil, it was pulverized by ultrasonication, filtered, and the precipitate was dried to form a white powder (1.3gr, yield:
81%). Elemental analysis values Actual value C; 64.63, H; 8.39 Theoretical value C; 66.02, H; 8.31 Melting point > 200℃ (decomposition point) Infrared absorption spectrum: shown in Figure 6 The ML-236C derivative represented by formula () is ML −
Like 236C, it inhibits hepatic cholesterol synthesis. However, its action is stronger than ML-236C. Therefore, ML−
236C derivatives can be used medicinally as hyperlipidemia therapeutics and arteriosclerosis preventive agents. Next, the cholesterol synthesis inhibitory effect of the ML-236C derivative will be shown. Cholesterol synthesis inhibitory effect: ML-236C derivatives are 3-hydroxy-3-
Methylglutaryl coenzyme A reductase (3-hydroxy-3-methylglutaryl-Co
It was found that the enzyme specifically inhibits A-areductase. Table 1 shows the cholesterol synthesis inhibitory effects of these compounds [measured by the method described in Journal of Biological Chemistry (J. Biol. Chem.) Vol. 234, p. 2835 (1959)]. 【table】
第1図はML−236Cメチルエステルの赤外線吸
収スペクトラム、第2図はML−236Cエチルエス
テルの赤外線吸収スペクトラム、第3図はML−
236C n−ブチルエステルの赤外線吸収スペクト
ラム、第4図はML−236Cベンジルエステルの赤
外線吸収スペクトラム、第5図はML−236Cナト
リウム塩の赤外線吸収スペクトラム、第6図は
ML−236Cカルシウム塩の赤外線吸収スペクトラ
ムを示す。
Figure 1 is the infrared absorption spectrum of ML-236C methyl ester, Figure 2 is the infrared absorption spectrum of ML-236C ethyl ester, and Figure 3 is ML-236C ethyl ester.
Infrared absorption spectrum of 236C n-butyl ester, Figure 4 is infrared absorption spectrum of ML-236C benzyl ester, Figure 5 is infrared absorption spectrum of ML-236C sodium salt, Figure 6 is
The infrared absorption spectrum of ML-236C calcium salt is shown.
Claims (1)
1/n・Mを示し、Mは金属元素、nは該金属元素
の原子価を示す。)で示されるML−236C誘導
体。[Claims] 1 formula (In the formula, R is an alkyl group; a benzyl group; or
1/n·M, where M is a metal element and n is the valence of the metal element. ) ML-236C derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5721080A JPS56154439A (en) | 1980-04-30 | 1980-04-30 | Ml-236c derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5721080A JPS56154439A (en) | 1980-04-30 | 1980-04-30 | Ml-236c derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56154439A JPS56154439A (en) | 1981-11-30 |
JPS6253494B2 true JPS6253494B2 (en) | 1987-11-10 |
Family
ID=13049146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5721080A Granted JPS56154439A (en) | 1980-04-30 | 1980-04-30 | Ml-236c derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56154439A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105985244A (en) * | 2015-02-04 | 2016-10-05 | 北京北大维信生物科技有限公司 | Compound as well as separation method, synthetic method and application thereof |
-
1980
- 1980-04-30 JP JP5721080A patent/JPS56154439A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS56154439A (en) | 1981-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1200384B1 (en) | 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production | |
JPS6360753B2 (en) | ||
US2734904A (en) | Xcxnhxc-nh | |
US3751458A (en) | Citroylformic acid and its production | |
US4073933A (en) | Novel bicycloheptene derivatives | |
US3925458A (en) | Process for preparing 2-(4-alkylphenyl)-propion-aldehyde and propionic acid | |
JPS6253494B2 (en) | ||
US2766255A (en) | alpha-methyltryptophane and salts thereof | |
SU645552A3 (en) | Method of obtaining carboxylic acids, or their salts, or esters | |
HU213315B (en) | Process for producing arylacetic acids and their alkali metal salts | |
US3927084A (en) | Process for the production of 2(4-alkylphenyl)propionic acid | |
RU1836332C (en) | Method for obtaining unsaturated derivatives of 2,6-diamino-heptandine acid or their pharmaceutically acceptable salts | |
US2820052A (en) | Production of chemical compounds | |
US2853497A (en) | 6, 8-bis (hydrocarbon substituted mercapto) 5-hydroxycaprylic acids and delta-lactones thereof | |
JPS5813539B2 (en) | Chikantetrazole Sanruino Seizouhou | |
JP3058399B2 (en) | [[4-Substituted acetyl-O-phenylene] dioxy] diacetate derivative and method for producing the same | |
CH659472A5 (en) | EPOXYCARBACYCLINE DERIVATIVES, THEIR PRODUCTION AND USE. | |
DE2506410C3 (en) | Process for the preparation of thiazolidinone acetic acid derivatives | |
SU831071A3 (en) | Method of preparing prostaglandine analogs | |
JPH02233692A (en) | Novel n6,2'-o-disubstituted-adenosine-3',5'-cyclic phosphate and production thereof | |
JP3216674B2 (en) | 5-Alkoxy-2,3,4,5-tetrahydro-3-oxoisoxazole and process for producing the same | |
JP3263377B2 (en) | Method for producing 3,5-dihydroxy-6-oxohexanoate derivative | |
JPH0140032B2 (en) | ||
JPH0517905B2 (en) | ||
JPH0830066B2 (en) | Method for producing thiotetronic acid |